Ir 2018 Limited
04265329
Some Concerns
- Negative net worth (-10)
Details
Compliance
Last accounts
31/03/2025
dormant
Next accounts due
31/12/2026
Confirmation statement
Last: 06/08/2025
Due 20/08/2026
Industry
Officers
director · Since 03/01/2024
PRESIDENT AND CEO
AMERICAN · UNITED STATES · Age 61
Also on 1 other board
Persons with Significant Control
Revolo Biotherapeutics Limited
C/O Bcs, Windsor House, Station Court, Cambridge, CB22 5NE
Reg: 07828414 · England And Wales · Private Company Limited By Shares
Notified 04/01/2018
Former PSCs
Professor Gabriel Stavros Panayi
Ceased 04/01/2018
Kingls College London
Ceased 04/01/2018
Wellcome Trust
Ceased 04/01/2018
Aramis International Limited
Ceased 04/01/2018
CompanyRankvs 568100+ SIC 74909 peers36
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
-£42k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£42k
Working capital
Current Assets
—
Current Liabilities
£42k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | — | -£1k |
| 2022 | 0.03 | — |
Derived from filed accounts. Not audited figures.